Non-motor fluctuations (NMFs) in Parkinson’s disease (PD) significantly affect patients’ well-being. Despite being identified over two decades ago, NMFs remain largely underrecognized, undertreated, and poorly understood. While they are often temporally associated with motor fluctuations (MFs) and can share common risk factors and pathophysiologic mechanisms, NMFs and MFs are currently considered distinct entities. The prevalence and severity of NMFs, often categorized into neuropsychiatric, sensory, and autonomic subtypes, vary significantly across studies due to the heterogeneous PD populations screened and the diverse evaluation tools applied. The consistent negative impact of NMFs on PD patients’ quality of life underscores the importance of further investigations via focused and controlled studies, validated assessment instruments and novel digital technologies. High-quality research is essential to illuminate the complex pathophysiology and clinical nuances of NMFs, ultimately enhancing clinicians’ diagnostic and treatment options in routine clinical practice.
Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson’s disease K. Ray Chaudhuri, Manon Bouchard, Eric Freire-Alvarez, Rajesh Pahwa, Lars Bergmann, Resmi Gupta, Pavnit Kukreja, Megha B. Shah, Stuart H. Isaacson Clinical Parkinsonism & Related Disorders.2025; 12: 100330. CrossRef
Motor fluctuations in Parkinson disease – a mini-review of emerging drugs Priti Gros, Laura Armengou Garcia, Susan H. Fox Expert Opinion on Emerging Drugs.2025; : 1. CrossRef
Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approaches Martin Regensburger, Ilona Csoti, Wolfgang H. Jost, Zacharias Kohl, Stefan Lorenzl, David J. Pedrosa, Paul Lingor Journal of Neural Transmission.2025;[Epub] CrossRef
Neuropsychiatric disorders in Parkinson’s disease Beatrice Heim, Atbin Djamshidian Therapeutic Advances in Neurological Disorders.2025;[Epub] CrossRef
Distinction and mutual Influences between Parkinson's Disease‐related and unrelated Chronic Pain Jonathan Hunger, Florian Brugger, Georg Kägi, Jens Carsten Möller, Nathalie Hollenstein, David H. Benninger, Michele Tinazzi, Julien F. Bally, Roman Gonzenbach, Daniel Ciampi de Andrade, Santiago Perez Lloret, Veit Mylius Movement Disorders Clinical Practice.2025;[Epub] CrossRef
Effects of levodopa–entacapone–carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson’s disease—interim analysis of the ELEGANCE study Tobias Warnecke, Per Odin, Rocío García-Ramos, Lydia Lopez, Delia Tulbă, Traian Flavius Dan, Dragos Catalin Jianu, Petra Bago Rožanković, Teus van Laar Journal of Neural Transmission.2025;[Epub] CrossRef
Treatment strategies for motor fluctuations in Parkinson’s disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America Oscar Arias-Carrión, Emmanuel Ortega-Robles Frontiers in Pharmacology.2025;[Epub] CrossRef
Non-motor symptoms in Parkinson’s disease: a practical approach Ann Subota, Veronica Bruno Practical Neurology.2025; : pn-2025-004696. CrossRef
The challenges with the identification of Parkinson’s disease subtypes Leonardo Rigon, Karolina Poplawska-Domaszewicz, Vinod Metta, Carmelo Fogliano, Maria Laura Nasi, Anna Sauerbier, Haider Dafsari, Valentina Leta, Cristian Falup-Pecurariu, Per Odin, Angelo Antonini, Kallol Ray Chaudhuri Expert Review of Neurotherapeutics.2025;[Epub] CrossRef